Very important paper below from CHOP A/I division researchers Stan Gabryszewski and Jonathan Spergel on the association between Dupilumab use and autoimmune conditions. An important consideration that warrants more investigation.
pubmed.ncbi.nlm.nih.gov/41895450/
We detected a modest association between dupilumab and cutaneous autoimmune disease diagnosis in atopic children. These findings help address knowledge gaps about clinical outcomes in atopic children treated with this biologic.
